Already more than 20 years ago an induction and mis-regulation of the expression of tumor necrosis factor alpha (TNFα) has been linked to the development of MASLD [13] and the role of TNFα in the onset and progression has since been investigated in many studies (for overview see [14]). This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.